🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Dianthus Therapeutics, Inc.
Market Cap: Medium
Employees: Lowest
DNTH103
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on designing, developing, and delivering novel monoclonal antibodies for severe autoimmune and inflammatory diseases. Their lead product, DNTH103, is in phase 1 clinical trials.
Website
Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About | About
Symbol: DNTH
Recent Price: $21.50
Industry: Biotechnology
CEO: Mr. Marino Garcia M.B.A.
Sector: Healthcare
Employees: 53
Address: 7 Times Square, New York, NY 10036
Phone: 929-999-4055
Last updated: 2024-12-31